Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Absolute lymphocyte count at day 29 of treatment is a powerful predictor of outcome in multiple myeloma.

Narwani V, Gabriel J, Boyd K, Chevassut T.

Clin Lymphoma Myeloma Leuk. 2015 Apr;15(4):222-6. doi: 10.1016/j.clml.2014.10.002. Epub 2014 Oct 23.

PMID:
25468320
2.

Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study.

Ege H, Gertz MA, Markovic SN, Lacy MQ, Dispenzieri A, Hayman SR, Kumar SK, Porrata LF.

Br J Haematol. 2008 Jun;141(6):792-8. doi: 10.1111/j.1365-2141.2008.07123.x. Epub 2008 Apr 10.

PMID:
18410454
4.

Absolute lymphocyte count as predictor of overall survival for patients with multiple myeloma treated with single autologous stem cell transplant.

Jimenez-Zepeda VH, Reece DE, Trudel S, Chen C, Franke N, Winter A, Tiedemann R, Kukreti V.

Leuk Lymphoma. 2015;56(9):2668-73. doi: 10.3109/10428194.2014.1003057. Epub 2015 Feb 24.

PMID:
25573201
5.

Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma.

Porrata LF, Ristow K, Habermann TM, Witzig TE, Inwards DJ, Markovic SN.

Am J Hematol. 2009 Feb;84(2):93-7. doi: 10.1002/ajh.21337.

6.

Early lymphocyte recovery predicts longer survival after autologous peripheral blood stem cell transplantation in multiple myeloma.

Kim H, Sohn HJ, Kim S, Lee JS, Kim WK, Suh C.

Bone Marrow Transplant. 2006 Jun;37(11):1037-42.

PMID:
16708062
7.

Clinical value of absolute lymphocyte counts before bortezomib-dexamethasone therapy in relapsed multiple myeloma patients.

Song MK, Chung JS, Joo YD, Lee SM, Lee GW, Lee HS, Kim SH, Yun EY, Seol YM, Kim SG, Shin HJ, Choi YJ, Cho GJ.

Acta Haematol. 2010;124(1):34-9. doi: 10.1159/000313654. Epub 2010 Jul 3.

PMID:
20606414
8.

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma.

Porrata LF, Gertz MA, Inwards DJ, Litzow MR, Lacy MQ, Tefferi A, Gastineau DA, Dispenzieri A, Ansell SM, Micallef IN, Geyer SM, Markovic SN.

Blood. 2001 Aug 1;98(3):579-85.

9.

Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia.

Sun D, Elson P, Liedtke M, Medeiros BC, Earl M, Alizadeh A, Bates J, Sekeres MA, Coutre S, Kalaycio M, Sobecks R, Copelan E, Advani AS.

Am J Hematol. 2012 Oct;87(10):957-60. doi: 10.1002/ajh.23279. Epub 2012 Jun 22.

10.

The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma.

Porrata LF, Gertz MA, Geyer SM, Litzow MR, Gastineau DA, Moore SB, Pineda AA, Bundy KL, Padley DJ, Persky D, Lacy MQ, Dispenzieri A, Snow DS, Markovic SN.

Leukemia. 2004 Jun;18(6):1085-92.

PMID:
15042106
11.

Early lymphocyte recovery following autologous peripheral stem cell transplantation is associated with better survival in younger patients with lymphoproliferative disorders.

Boulassel MR, Herr AL, deB Edwardes MD, Galal A, Lachance S, Laneuville P, Routy JP.

Hematology. 2006 Jun;11(3):165-70.

PMID:
17325956
12.

Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia.

Behl D, Porrata LF, Markovic SN, Letendre L, Pruthi RK, Hook CC, Tefferi A, Elliot MA, Kaufmann SH, Mesa RA, Litzow MR.

Leukemia. 2006 Jan;20(1):29-34.

PMID:
16281063
13.

Host immunity affects survival in myelodysplastic syndromes: Independent prognostic value of the absolute lymphocyte count.

Jacobs NL, Holtan SG, Porrata LF, Markovic SN, Tefferi A, Steensma DP.

Am J Hematol. 2010 Mar;85(3):160-3. doi: 10.1002/ajh.21618.

14.
15.

Absolute lymphocyte count: a potential prognostic factor for Merkel cell carcinoma.

Johnson ME, Zhu F, Li T, Wu H, Galloway TJ, Farma JM, Perlis CS, Turaka A.

J Am Acad Dermatol. 2014 Jun;70(6):1028-35. doi: 10.1016/j.jaad.2014.01.890. Epub 2014 Mar 22.

PMID:
24666998
16.

Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma.

Porrata LF, Litzow MR, Inwards DJ, Gastineau DA, Moore SB, Pineda AA, Bundy KL, Padley DJ, Persky D, Ansell SM, Micallef IN, Markovic SN.

Bone Marrow Transplant. 2004 Feb;33(3):291-8.

PMID:
14676784
17.

Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era.

Watanabe R, Tomita N, Itabashi M, Ishibashi D, Yamamoto E, Koyama S, Miyashita K, Takahashi H, Nakajima Y, Hattori Y, Motohashi K, Takasaki H, Ohshima R, Hashimoto C, Yamazaki E, Fujimaki K, Sakai R, Fujisawa S, Motomura S, Ishigatsubo Y.

Eur J Haematol. 2014 Mar;92(3):204-10. doi: 10.1111/ejh.12221. Epub 2013 Nov 28.

PMID:
24283206
18.

Complete response after autologous stem cell transplant in multiple myeloma.

Kumar L, Iqbal N, Mookerjee A, Verma RK, Sharma OD, Batra A, Pramanik R, Gupta R.

Cancer Med. 2014 Aug;3(4):939-46. doi: 10.1002/cam4.257. Epub 2014 Apr 29.

19.

Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab.

Oki Y, Yamamoto K, Kato H, Kuwatsuka Y, Taji H, Kagami Y, Morishima Y.

Eur J Haematol. 2008 Dec;81(6):448-53. doi: 10.1111/j.1600-0609.2008.01129.x. Epub 2008 Aug 6.

PMID:
18691256
20.

Peripheral blood lymphocyte/monocyte ratio predicts outcome for patients with diffuse large B cell lymphoma after standard first-line regimens.

Li YL, Pan YY, Jiao Y, Ning J, Fan YG, Zhai ZM.

Ann Hematol. 2014 Apr;93(4):617-26. doi: 10.1007/s00277-013-1916-9. Epub 2013 Oct 19.

PMID:
24141331

Supplemental Content

Support Center